These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 33722703)

  • 21. Retrospective study on the impact of COVID-19 lockdown on patients with type 2 diabetes in Northern Jordan.
    Alyahya MS; Okour NS; Khader Y; Al-Sheyab N
    BMJ Open; 2022 Nov; 12(11):e065148. PubMed ID: 36351713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term impact of COVID-19 lockdown on metabolic control of patients with well-controlled type 2 diabetes: a single-centre observational study.
    Biancalana E; Parolini F; Mengozzi A; Solini A
    Acta Diabetol; 2021 Apr; 58(4):431-436. PubMed ID: 33219884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 Diabetes prone to hypoglycemia using standalone continuous glucose monitoring.
    Mesa A; Viñals C; Pueyo I; Roca D; Vidal M; Giménez M; Conget I
    Diabetes Res Clin Pract; 2020 Sep; 167():108354. PubMed ID: 32739380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycemic Control Improvement in Italian Children and Adolescents With Type 1 Diabetes Followed Through Telemedicine During Lockdown Due to the COVID-19 Pandemic.
    Predieri B; Leo F; Candia F; Lucaccioni L; Madeo SF; Pugliese M; Vivaccia V; Bruzzi P; Iughetti L
    Front Endocrinol (Lausanne); 2020; 11():595735. PubMed ID: 33424771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of a prolonged lockdown and use of telemedicine on glycemic control in people with type 1 diabetes during the COVID-19 outbreak in Saudi Arabia.
    Alharthi SK; Alyusuf EY; Alguwaihes AM; Alfadda A; Al-Sofiani ME
    Diabetes Res Clin Pract; 2021 Mar; 173():108682. PubMed ID: 33539868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of COVID-19 pandemic on glycemic control among outpatients with type 2 diabetes in Japan: A hospital-based survey from a country without lockdown.
    Tanji Y; Sawada S; Watanabe T; Mita T; Kobayashi Y; Murakami T; Metoki H; Akai H
    Diabetes Res Clin Pract; 2021 Jun; 176():108840. PubMed ID: 33933499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of COVID-19 lockdown on glycemic control in patients with type 2 diabetes mellitus in Turkey.
    Önmez A; Gamsızkan Z; Özdemir Ş; Kesikbaş E; Gökosmanoğlu F; Torun S; Cinemre H
    Diabetes Metab Syndr; 2020; 14(6):1963-1966. PubMed ID: 33059299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased stress, weight gain and less exercise in relation to glycemic control in people with type 1 and type 2 diabetes during the COVID-19 pandemic.
    Ruissen MM; Regeer H; Landstra CP; Schroijen M; Jazet I; Nijhoff MF; Pijl H; Ballieux BEPB; Dekkers O; Huisman SD; de Koning EJP
    BMJ Open Diabetes Res Care; 2021 Jan; 9(1):. PubMed ID: 33431602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronavirus lockdown effect on type 1 diabetes management οn children wearing insulin pump equipped with continuous glucose monitoring system.
    Christoforidis A; Kavoura E; Nemtsa A; Pappa K; Dimitriadou M
    Diabetes Res Clin Pract; 2020 Aug; 166():108307. PubMed ID: 32650036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment.
    Nauck MA; Haastert B; Trautner C; Müller UA; Nauck MA; Heinemann L;
    Diabetologia; 2014 May; 57(5):868-77. PubMed ID: 24445534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of COVID-19 lockdown on glycemic control in patients with type 1 diabetes.
    Fernández E; Cortazar A; Bellido V
    Diabetes Res Clin Pract; 2020 Aug; 166():108348. PubMed ID: 32711000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of COVID-19 lockdown on the glycemic control of children with type 1 diabetes.
    Hakonen E; Varimo T; Tuomaala AK; Miettinen PJ; Pulkkinen MA
    BMC Pediatr; 2022 Jan; 22(1):48. PubMed ID: 35045807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of structured self-monitoring of blood glucose, with and without additional TeleCare support, on overall glycaemic control in non-insulin treated Type 2 diabetes: the SMBG Study, a 12-month randomized controlled trial.
    Parsons SN; Luzio SD; Harvey JN; Bain SC; Cheung WY; Watkins A; Owens DR
    Diabet Med; 2019 May; 36(5):578-590. PubMed ID: 30653704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycaemic control in the paediatric and young adult population with type 1 diabetes following a single telehealth visit - what have we learned from the COVID-19 lockdown?
    Rachmiel M; Lebenthal Y; Mazor-Aronovitch K; Brener A; Levek N; Levran N; Chorna E; Dekel M; Barash G; Landau Z; Pinhas-Hamiel O
    Acta Diabetol; 2021 Jun; 58(6):697-705. PubMed ID: 33511493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of COVID-19 lockdown on people living with diabetes: Experience from a low-middle income country in South Asia.
    Dissanayake H; Soysa P; Samarathunga T; De Silva L; Samaranayake N; Padmaperuma C; Katulanda P
    Prim Care Diabetes; 2022 Feb; 16(1):127-134. PubMed ID: 34974994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acceptability and Utilization of Newer Technologies and Effects on Glycemic Control in Type 2 Diabetes: Lessons Learned from Lockdown.
    Anjana RM; Pradeepa R; Deepa M; Jebarani S; Venkatesan U; Parvathi SJ; Balasubramanyam M; Radha V; Poongothai S; Sudha V; Shanthi Rani CS; Ranjani H; Amutha A; Manickam N; Unnikrishnan R; Mohan V
    Diabetes Technol Ther; 2020 Jul; 22(7):527-534. PubMed ID: 32522031
    [No Abstract]   [Full Text] [Related]  

  • 37. Impact of insulin initiation on glycaemic variability and glucose profiles in a primary healthcare Type 2 diabetes cohort: analysis of continuous glucose monitoring data from the INITIATION study.
    Manski-Nankervis J; Yates CJ; Blackberry I; Furler J; Ginnivan L; Cohen N; Jenkins A; Vasanthakumar S; Gorelik A; Young D; Best J; O'Neal D
    Diabet Med; 2016 Jun; 33(6):803-11. PubMed ID: 26435033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Has COVID-19 lockdown improved glycaemic control in pediatric patients with type 1 diabetes? An analysis of continuous glucose monitoring metrics.
    Lombardo F; Salzano G; Bombaci B; Basile P; Lucania G; Alibrandi A; Passanisi S
    Diabetes Res Clin Pract; 2021 Aug; 178():108988. PubMed ID: 34331977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of SARS-CoV-2 Lockdown on Glycaemic Control: A Retrospective Observational Cohort Study in a Tertiary Setting.
    Zechmann S; Hotz L; Di Gangi S; Baumgartl K; Plate A; Potlukova E
    J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement in glycaemic control in paediatric and young adult type 1 diabetes patients during COVID-19 pandemic: role of telemedicine and lifestyle changes.
    Lazzeroni P; Motta M; Monaco S; Laudisio SR; Furoncoli D; Maffini V; Rubini M; Tchana B; Ruberto C; Dodi I; Iovane B
    Acta Biomed; 2021 Nov; 92(5):e2021399. PubMed ID: 34738562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.